Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | ATM | Q13315 | 1/20 | 0.34 |
| ▸ | PDE4A | P27815 | 1/20 | 0.32 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.32 |
| ▸ | PDE4C | Q08493 | 1/20 | 0.32 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.32 |
| ▸ | COMT | P21964 | 1/20 | 0.31 |
| ▸ | PPARG | P37231 | 3/20 | 0.31 |
| ▸ | PPARA | Q07869 | 2/20 | 0.31 |
| ▸ | NPC1 | O15118 | 1/20 | 0.30 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.30 |
| ▸ | AKT1 | P31749 | 1/20 | 0.30 |
| ▸ | AKT2 | P31751 | 1/20 | 0.30 |
| ▸ | AKT3 | Q9Y243 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL261528 | 0.91 | KDM4E (0.41) | L3MBTL1KDM4EATMPDE4APDE4B | |
| SCHEMBL15695210 | 0.90 | KDM4E (0.43) | L3MBTL1KDM4EATMPDE4APDE4B | |
| SCHEMBL17680374 | 0.87 | L3MBTL1 (0.38) | L3MBTL1KDM4EATMCOMTPPARG | |
| SCHEMBL13811428 | 0.84 | MAOA (0.39) | L3MBTL1KDM4EATMCOMTNPC1 | |
| SCHEMBL12113727 | 0.84 | KDM4E (0.48) | L3MBTL1KDM4EATMPPARGPPARA | |
| SCHEMBL17425807 | 0.81 | HTT (0.33) | L3MBTL1KDM4EATMCOMTPPARG | |
| SCHEMBL12383114 | 0.79 | KCNH2 (0.36) | L3MBTL1NPC1HSP90AA1AKT1AKT2 | |
| SCHEMBL23838485 | 0.78 | KDM4E (0.30) | L3MBTL1KDM4EATM | |
| SCHEMBL21674421 | 0.76 | KDM4E (0.48) | L3MBTL1KDM4EATMPPARGPPARA | |
| SCHEMBL11978685 | 0.76 | ALDH1A1 (0.47) | L3MBTL1KDM4EATMCOMTNPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10644251-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2020-05-05 | — | — | US | disclosed |
| US-20150155501-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2015-06-04 | — | — | US | disclosed |
| US-20150155501-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2015-06-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10644251-B2 | Organic electroluminescent materials and devices | RUVBL1, RUVBL2, LIFR | L3MBTL1 97/4885KDM4E 3302/4885ATM 1265/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.